Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

15th Milan Breast Cancer Conference /
Breast cancer treatment and prevention with tamoxifen and SERMS

20th - 21st Jun 2013

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 15.07.13
Views: 3819
Rating:

Dr Andrea De Censi - E.O. Ospedale Galliera, Genova, Italy

Dr Andrea De Censi talks to ecancer at MBCC 15 about selective oestrogen receptor modulators (SERMS) and tamoxifen, as well as a number of phase III double blind trials.  

Dr De Censi discusses how there are very effective drugs for breast cancer prevention, but the medical community is still largely unaware of this.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation